ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 164 filers reported holding ANIKA THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 3.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $1,830,000 | -9.9% | 44,875 | 0.0% | 1.59% | -25.5% |
Q4 2020 | $2,031,000 | +35.4% | 44,875 | +5.9% | 2.14% | +13.3% |
Q3 2020 | $1,500,000 | -6.2% | 42,375 | 0.0% | 1.89% | -15.9% |
Q2 2020 | $1,599,000 | +30.5% | 42,375 | 0.0% | 2.24% | +11.0% |
Q1 2020 | $1,225,000 | – | 42,375 | – | 2.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthInvest Partners AB | 490,331 | $21,928,000 | 10.27% |
CAPITAL MANAGEMENT CORP /VA | 211,660 | $9,465,000 | 3.66% |
AMI ASSET MANAGEMENT CORP | 336,791 | $15,061,000 | 1.03% |
Baltimore-Washington Financial Advisors, Inc. | 68,785 | $3,076,000 | 0.93% |
Portolan Capital Management | 130,939 | $5,856,000 | 0.78% |
Kalos Management, Inc. | 19,254 | $861,000 | 0.72% |
DIKER MANAGEMENT LLC | 32,965 | $1,474,000 | 0.56% |
THOMPSON SIEGEL & WALMSLEY LLC | 1,526,244 | $68,253,000 | 0.56% |
NEW AMSTERDAM PARTNERS LLC/NY | 108,260 | $4,841,000 | 0.51% |
Boston Trust Walden Corp | 493,780 | $22,082,000 | 0.38% |